Screening  ||| S:0 E:10 ||| VBG
for  ||| S:10 E:14 ||| IN
depression  ||| S:14 E:25 ||| NN
in  ||| S:25 E:28 ||| IN
post  ||| S:28 E:33 ||| NN
stroke  ||| S:33 E:40 ||| NN
patients  ||| S:40 E:49 ||| NNS
depression  ||| S:49 E:60 ||| NN
has  ||| S:60 E:64 ||| VBZ
a  ||| S:64 E:66 ||| DT
significant  ||| S:66 E:78 ||| JJ
prevalence  ||| S:78 E:89 ||| NN
in  ||| S:89 E:92 ||| IN
patients  ||| S:92 E:101 ||| NNS
following  ||| S:101 E:111 ||| VBG
a  ||| S:111 E:113 ||| DT
stroke ||| S:113 E:119 ||| NN
.  ||| S:119 E:121 ||| .
Studies  ||| S:121 E:129 ||| NNS
have  ||| S:129 E:134 ||| VBP
found  ||| S:134 E:140 ||| VBN
rates  ||| S:140 E:146 ||| NNS
to  ||| S:146 E:149 ||| TO
be  ||| S:149 E:152 ||| VB
between  ||| S:152 E:160 ||| IN
25-54 ||| S:160 E:165 ||| CD
% ||| S:165 E:166 ||| NN
.  ||| S:166 E:168 ||| .
Within  ||| S:168 E:175 ||| IN
this  ||| S:175 E:180 ||| DT
audit  ||| S:180 E:186 ||| NN
we  ||| S:186 E:189 ||| PRP
aimed  ||| S:189 E:195 ||| VBD
to  ||| S:195 E:198 ||| TO
ascertain  ||| S:198 E:208 ||| VB
the  ||| S:208 E:212 ||| DT
proportion  ||| S:212 E:223 ||| NN
of  ||| S:223 E:226 ||| IN
patients  ||| S:226 E:235 ||| NNS
who  ||| S:235 E:239 ||| WP
have  ||| S:239 E:244 ||| VBP
been  ||| S:244 E:249 ||| VBN
identified  ||| S:249 E:260 ||| VBN
as  ||| S:260 E:263 ||| IN
having  ||| S:263 E:270 ||| VBG
depression ||| S:270 E:280 ||| NN
,  ||| S:280 E:282 ||| ,
and  ||| S:282 E:286 ||| CC
explore  ||| S:286 E:294 ||| VB
the  ||| S:294 E:298 ||| DT
methods  ||| S:298 E:306 ||| NNS
employed  ||| S:306 E:315 ||| VBN
to  ||| S:315 E:318 ||| TO
identify  ||| S:318 E:327 ||| VB
depressed  ||| S:327 E:337 ||| JJ
patients ||| S:337 E:345 ||| NNS
.  ||| S:345 E:347 ||| .
We  ||| S:347 E:350 ||| PRP
also  ||| S:350 E:355 ||| RB
looked  ||| S:355 E:362 ||| VBN
to  ||| S:362 E:365 ||| TO
assess  ||| S:365 E:372 ||| VB
the  ||| S:372 E:376 ||| DT
number  ||| S:376 E:383 ||| NN
of  ||| S:383 E:386 ||| IN
these  ||| S:386 E:392 ||| DT
patients  ||| S:392 E:401 ||| NNS
who  ||| S:401 E:405 ||| WP
have  ||| S:405 E:410 ||| VBP
been  ||| S:410 E:415 ||| VBN
treated  ||| S:415 E:423 ||| VBN
for  ||| S:423 E:427 ||| IN
depression  ||| S:427 E:438 ||| NN
and  ||| S:438 E:442 ||| CC
to  ||| S:442 E:445 ||| TO
explore  ||| S:445 E:453 ||| VB
the  ||| S:453 E:457 ||| DT
medications  ||| S:457 E:469 ||| NN
used  ||| S:469 E:474 ||| VBN
for  ||| S:474 E:478 ||| IN
the  ||| S:478 E:482 ||| DT
treatment  ||| S:482 E:492 ||| NN
of  ||| S:492 E:495 ||| IN
depression.  ||| S:495 E:507 ||| CD
this  ||| S:507 E:512 ||| DT
audit  ||| S:512 E:518 ||| NN
was  ||| S:518 E:522 ||| VBD
conducted  ||| S:522 E:532 ||| VBN
in  ||| S:532 E:535 ||| IN
two  ||| S:535 E:539 ||| CD
phases ||| S:539 E:545 ||| NNS
.  ||| S:545 E:547 ||| .
Initially  ||| S:547 E:557 ||| RB
an  ||| S:557 E:560 ||| DT
audit  ||| S:560 E:566 ||| NN
was  ||| S:566 E:570 ||| VBD
conducted  ||| S:570 E:580 ||| VBN
to  ||| S:580 E:583 ||| TO
establish  ||| S:583 E:593 ||| VB
the  ||| S:593 E:597 ||| DT
current  ||| S:597 E:605 ||| JJ
prevalence ||| S:605 E:615 ||| NN
,  ||| S:615 E:617 ||| ,
screening  ||| S:617 E:627 ||| VBG
and  ||| S:627 E:631 ||| CC
management  ||| S:631 E:642 ||| NN
of  ||| S:642 E:645 ||| IN
depression  ||| S:645 E:656 ||| NN
in  ||| S:656 E:659 ||| IN
post-stroke  ||| S:659 E:671 ||| JJ
patients ||| S:671 E:679 ||| NNS
.  ||| S:679 E:681 ||| .
Following  ||| S:681 E:691 ||| VBG
this ||| S:691 E:695 ||| DT
,  ||| S:695 E:697 ||| ,
we  ||| S:697 E:700 ||| PRP
introduced  ||| S:700 E:711 ||| VBD
the  ||| S:711 E:715 ||| DT
PHQ-9  ||| S:715 E:721 ||| NN
as  ||| S:721 E:724 ||| IN
a  ||| S:724 E:726 ||| DT
screening  ||| S:726 E:736 ||| NN
tool  ||| S:736 E:741 ||| NN
for  ||| S:741 E:745 ||| IN
depression  ||| S:745 E:756 ||| NN
and  ||| S:756 E:760 ||| CC
a  ||| S:760 E:762 ||| DT
re-audited  ||| S:762 E:773 ||| JJ
at  ||| S:773 E:776 ||| IN
four  ||| S:776 E:781 ||| CD
months ||| S:781 E:787 ||| NNS
.  ||| S:787 E:789 ||| .
In  ||| S:789 E:792 ||| IN
phase  ||| S:792 E:798 ||| NN
2 ||| S:798 E:799 ||| CD
,  ||| S:799 E:801 ||| ,
All  ||| S:801 E:805 ||| DT
patients  ||| S:805 E:814 ||| NNS
admitted  ||| S:814 E:823 ||| VBD
to  ||| S:823 E:826 ||| TO
the  ||| S:826 E:830 ||| DT
stoke  ||| S:830 E:836 ||| JJ
ward  ||| S:836 E:841 ||| NN
in  ||| S:841 E:844 ||| IN
Bedford  ||| S:844 E:852 ||| NNP
hospital  ||| S:852 E:861 ||| NN
between  ||| S:861 E:869 ||| IN
10 ||| S:869 E:871 ||| CD
/ ||| S:871 E:872 ||| CD
9 ||| S:872 E:873 ||| CD
/ ||| S:873 E:874 ||| CD
09  ||| S:874 E:877 ||| CD
and  ||| S:877 E:881 ||| CC
13 ||| S:881 E:883 ||| CD
/ ||| S:883 E:884 ||| CD
12 ||| S:884 E:886 ||| CD
/ ||| S:886 E:887 ||| CD
09  ||| S:887 E:890 ||| CD
were  ||| S:890 E:895 ||| VBD
included  ||| S:895 E:904 ||| VBN
in  ||| S:904 E:907 ||| IN
the  ||| S:907 E:911 ||| DT
audit ||| S:911 E:916 ||| NN
.  ||| S:916 E:918 ||| .
Patients  ||| S:918 E:927 ||| NNS
were  ||| S:927 E:932 ||| VBD
screened  ||| S:932 E:941 ||| VBN
for  ||| S:941 E:945 ||| IN
depression  ||| S:945 E:956 ||| NN
using  ||| S:956 E:962 ||| VBG
the  ||| S:962 E:966 ||| DT
PHQ-9  ||| S:966 E:972 ||| CD
questionnaire  ||| S:972 E:986 ||| CD
two  ||| S:986 E:990 ||| CD
weeks  ||| S:990 E:996 ||| NNS
after  ||| S:996 E:1002 ||| IN
admission.  ||| S:1002 E:1013 ||| CD
the  ||| S:1013 E:1017 ||| DT
incidence  ||| S:1017 E:1027 ||| NN
of  ||| S:1027 E:1030 ||| IN
depression  ||| S:1030 E:1041 ||| NN
within  ||| S:1041 E:1048 ||| IN
the  ||| S:1048 E:1052 ||| DT
phase  ||| S:1052 E:1058 ||| NN
one  ||| S:1058 E:1062 ||| CD
group  ||| S:1062 E:1068 ||| NN
was  ||| S:1068 E:1072 ||| VBD
28 ||| S:1072 E:1074 ||| CD
% ||| S:1074 E:1075 ||| NN
.  ||| S:1075 E:1077 ||| .
In  ||| S:1077 E:1080 ||| IN
9  ||| S:1080 E:1082 ||| CD
of  ||| S:1082 E:1085 ||| IN
these  ||| S:1085 E:1091 ||| DT
cases  ||| S:1091 E:1097 ||| NNS
there  ||| S:1097 E:1103 ||| EX
was  ||| S:1103 E:1107 ||| VBD
no  ||| S:1107 E:1110 ||| DT
record  ||| S:1110 E:1117 ||| NN
of  ||| S:1117 E:1120 ||| IN
mood  ||| S:1120 E:1125 ||| NN
assessment  ||| S:1125 E:1136 ||| NN
or  ||| S:1136 E:1139 ||| CC
diagnosis  ||| S:1139 E:1149 ||| NN
of  ||| S:1149 E:1152 ||| IN
depression  ||| S:1152 E:1163 ||| NN
in  ||| S:1163 E:1166 ||| IN
the  ||| S:1166 E:1170 ||| DT
medical  ||| S:1170 E:1178 ||| JJ
notes ||| S:1178 E:1183 ||| NNS
.  ||| S:1183 E:1185 ||| .
Thirteen  ||| S:1185 E:1194 ||| VBG
out  ||| S:1194 E:1198 ||| RP
of  ||| S:1198 E:1201 ||| IN
60  ||| S:1201 E:1204 ||| CD
patients  ||| S:1204 E:1213 ||| NNS
were  ||| S:1213 E:1218 ||| VBD
prescribed  ||| S:1218 E:1229 ||| VBN
psychotropic  ||| S:1229 E:1242 ||| JJ
agents  ||| S:1242 E:1249 ||| NNS
during  ||| S:1249 E:1256 ||| IN
their  ||| S:1256 E:1262 ||| PRP$
stay ||| S:1262 E:1266 ||| NN
.  ||| S:1266 E:1268 ||| .
In  ||| S:1268 E:1271 ||| IN
phase  ||| S:1271 E:1277 ||| NN
2 ||| S:1277 E:1278 ||| CD
,  ||| S:1278 E:1280 ||| ,
Of  ||| S:1280 E:1283 ||| IN
the  ||| S:1283 E:1287 ||| DT
18  ||| S:1287 E:1290 ||| CD
patients  ||| S:1290 E:1299 ||| NNS
screened ||| S:1299 E:1307 ||| VBD
,  ||| S:1307 E:1309 ||| ,
10  ||| S:1309 E:1312 ||| CD
patients  ||| S:1312 E:1321 ||| NNS
( ||| S:1321 E:1322 ||| -LRB-
56 ||| S:1322 E:1324 ||| CD
% ||| S:1324 E:1325 ||| NN
)  ||| S:1325 E:1327 ||| -RRB-
scored  ||| S:1327 E:1334 ||| VBD
5  ||| S:1334 E:1336 ||| CD
or  ||| S:1336 E:1339 ||| CC
above ||| S:1339 E:1344 ||| RB
,  ||| S:1344 E:1346 ||| ,
which  ||| S:1346 E:1352 ||| WDT
according  ||| S:1352 E:1362 ||| VBZ
to  ||| S:1362 E:1365 ||| TO
the  ||| S:1365 E:1369 ||| DT
scoring  ||| S:1369 E:1377 ||| JJ
system  ||| S:1377 E:1384 ||| NN
of  ||| S:1384 E:1387 ||| IN
the  ||| S:1387 E:1391 ||| DT
PHQ-9  ||| S:1391 E:1397 ||| NNP
is  ||| S:1397 E:1400 ||| VBZ
indicative  ||| S:1400 E:1411 ||| VBN
of  ||| S:1411 E:1414 ||| IN
depression ||| S:1414 E:1424 ||| NN
.  ||| S:1424 E:1426 ||| .
One  ||| S:1426 E:1430 ||| CD
patient  ||| S:1430 E:1438 ||| NN
scored  ||| S:1438 E:1445 ||| VBD
10  ||| S:1445 E:1448 ||| CD
indicative  ||| S:1448 E:1459 ||| NN
of  ||| S:1459 E:1462 ||| IN
moderate  ||| S:1462 E:1471 ||| JJ
depression  ||| S:1471 E:1482 ||| NN
and  ||| S:1482 E:1486 ||| CC
one  ||| S:1486 E:1490 ||| CD
patient  ||| S:1490 E:1498 ||| NN
scored  ||| S:1498 E:1505 ||| VBD
19  ||| S:1505 E:1508 ||| CD
indicative  ||| S:1508 E:1519 ||| NN
of  ||| S:1519 E:1522 ||| IN
moderately  ||| S:1522 E:1533 ||| RB
severe  ||| S:1533 E:1540 ||| JJ
depression.  ||| S:1540 E:1552 ||| CD
phase  ||| S:1552 E:1558 ||| CD
1  ||| S:1558 E:1560 ||| CD
of  ||| S:1560 E:1563 ||| IN
this  ||| S:1563 E:1568 ||| DT
audit  ||| S:1568 E:1574 ||| NN
revealed  ||| S:1574 E:1583 ||| VBD
that  ||| S:1583 E:1588 ||| IN
there  ||| S:1588 E:1594 ||| EX
was  ||| S:1594 E:1598 ||| VBD
no  ||| S:1598 E:1601 ||| DT
formal  ||| S:1601 E:1608 ||| JJ
screening  ||| S:1608 E:1618 ||| NN
tool  ||| S:1618 E:1623 ||| NN
in  ||| S:1623 E:1626 ||| IN
use  ||| S:1626 E:1630 ||| NN
to  ||| S:1630 E:1633 ||| TO
identify  ||| S:1633 E:1642 ||| VB
depression  ||| S:1642 E:1653 ||| NN
in  ||| S:1653 E:1656 ||| IN
post  ||| S:1656 E:1661 ||| NN
stroke  ||| S:1661 E:1668 ||| NN
patients ||| S:1668 E:1676 ||| NNS
.  ||| S:1676 E:1678 ||| .
Consequently  ||| S:1678 E:1691 ||| RB
we  ||| S:1691 E:1694 ||| PRP
found  ||| S:1694 E:1700 ||| VBD
the  ||| S:1700 E:1704 ||| DT
prevalence  ||| S:1704 E:1715 ||| NN
to  ||| S:1715 E:1718 ||| TO
be  ||| S:1718 E:1721 ||| VB
28 ||| S:1721 E:1723 ||| CD
% ||| S:1723 E:1724 ||| NN
.  ||| S:1724 E:1726 ||| .
This  ||| S:1726 E:1731 ||| DT
correlates  ||| S:1731 E:1742 ||| NN
with  ||| S:1742 E:1747 ||| IN
the  ||| S:1747 E:1751 ||| DT
lower  ||| S:1751 E:1757 ||| JJR
end  ||| S:1757 E:1761 ||| NN
of  ||| S:1761 E:1764 ||| IN
the  ||| S:1764 E:1768 ||| DT
rate  ||| S:1768 E:1773 ||| NN
expected  ||| S:1773 E:1782 ||| VBN
within  ||| S:1782 E:1789 ||| IN
this  ||| S:1789 E:1794 ||| DT
group  ||| S:1794 E:1800 ||| NN
according  ||| S:1800 E:1810 ||| VBG
to  ||| S:1810 E:1813 ||| TO
the  ||| S:1813 E:1817 ||| DT
literature ||| S:1817 E:1827 ||| NN
.  ||| S:1827 E:1829 ||| .
As  ||| S:1829 E:1832 ||| IN
no  ||| S:1832 E:1835 ||| DT
screening  ||| S:1835 E:1845 ||| NN
tool  ||| S:1845 E:1850 ||| NN
was  ||| S:1850 E:1854 ||| VBD
being  ||| S:1854 E:1860 ||| VBG
used ||| S:1860 E:1864 ||| VBN
,  ||| S:1864 E:1866 ||| ,
practice  ||| S:1866 E:1875 ||| NN
was  ||| S:1875 E:1879 ||| VBD
not  ||| S:1879 E:1883 ||| RB
in  ||| S:1883 E:1886 ||| IN
accordance  ||| S:1886 E:1897 ||| NN
with  ||| S:1897 E:1902 ||| IN
the  ||| S:1902 E:1906 ||| DT
standards  ||| S:1906 E:1916 ||| NNS
set  ||| S:1916 E:1920 ||| VBN
by  ||| S:1920 E:1923 ||| IN
NICE  ||| S:1923 E:1928 ||| NNP
guidelines ||| S:1928 E:1938 ||| NNS
.  ||| S:1938 E:1940 ||| .
This  ||| S:1940 E:1945 ||| DT
led  ||| S:1945 E:1949 ||| VBN
us  ||| S:1949 E:1952 ||| PRP
to  ||| S:1952 E:1955 ||| TO
introduce  ||| S:1955 E:1965 ||| VB
the  ||| S:1965 E:1969 ||| DT
PHQ-9  ||| S:1969 E:1975 ||| JJ
screening  ||| S:1975 E:1985 ||| NN
tool  ||| S:1985 E:1990 ||| NN
in  ||| S:1990 E:1993 ||| IN
phase  ||| S:1993 E:1999 ||| NN
2 ||| S:1999 E:2000 ||| CD
.  ||| S:2000 E:2002 ||| .
Following  ||| S:2002 E:2012 ||| VBG
this ||| S:2012 E:2016 ||| DT
,  ||| S:2016 E:2018 ||| ,
we  ||| S:2018 E:2021 ||| PRP
found  ||| S:2021 E:2027 ||| VBD
the  ||| S:2027 E:2031 ||| DT
prevalence  ||| S:2031 E:2042 ||| NN
of  ||| S:2042 E:2045 ||| IN
depression  ||| S:2045 E:2056 ||| NN
had  ||| S:2056 E:2060 ||| VBD
increased  ||| S:2060 E:2070 ||| VBN
from  ||| S:2070 E:2075 ||| IN
28 ||| S:2075 E:2077 ||| CD
%  ||| S:2077 E:2079 ||| NN
to  ||| S:2079 E:2082 ||| TO
56 ||| S:2082 E:2084 ||| CD
% ||| S:2084 E:2085 ||| NN
.  ||| S:2085 E:2087 ||| .
these  ||| S:2087 E:2093 ||| DT
results  ||| S:2093 E:2101 ||| NNS
highlight  ||| S:2101 E:2111 ||| VB
the  ||| S:2111 E:2115 ||| DT
importance  ||| S:2115 E:2126 ||| NN
of  ||| S:2126 E:2129 ||| IN
formal  ||| S:2129 E:2136 ||| JJ
screening  ||| S:2136 E:2146 ||| NN
in  ||| S:2146 E:2149 ||| IN
order  ||| S:2149 E:2155 ||| NN
to  ||| S:2155 E:2158 ||| TO
reliably  ||| S:2158 E:2167 ||| RB
identify  ||| S:2167 E:2176 ||| VB
patients  ||| S:2176 E:2185 ||| NNS
who  ||| S:2185 E:2189 ||| WP
have  ||| S:2189 E:2194 ||| VBP
signs  ||| S:2194 E:2200 ||| NNS
of  ||| S:2200 E:2203 ||| IN
depression ||| S:2203 E:2213 ||| NN
.  ||| S:2213 E:2215 ||| .
